The clinical sector has seen a tremendous increase in the use of rapid methods for the detection and identification of pathogenic microorganisms, and the pharmaceutical industry can learn from these experiences. In our latest Newsletter, we reviewed select abstracts from the current edition of the Journal of Clinical Microbiology, where almost one-third of the bacteriology-related papers focused on rapid microbiological and molecular methods.
To read our review, please sign up for our Newsletter at: http://rapidmicromethods.com/newsletter/.
To read our review, please sign up for our Newsletter at: http://rapidmicromethods.com/newsletter/.